PEDIATRICS Vol. 18 No. 1 July 1956, pp. 38
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Hypoglycemic Action of Sulfonylureas in Patients with Diabetes Mellitus

Recent reports from Germany have stimulated renewed interest in an action of certain sulfonamide compounds on the blood sugar in diabetes mellitus. A class of sulfonamide compounds termed sulfonylureas have been shown to have a hypoglycemic effect and to eliminate the need for exogenous insulin in many adults with diabetes mellitus. This effect is believed to be due to an action of sulfonylureas as inhibitors of an enzyme responsible for the destruction of insulin (insulinase). Sulfonylureas have been most effective in adults with mild diabetes acquired late in life. Diabetes in childhood and adolescence, or in those in whom it has persisted for many years, have shown little or no response to the administration of sulfonylureas. The usefulness of these compounds in the treatment of patients with diabetes mellitus has not been determined and must be ascertained by careful clinical trials.